Embarking on the frontier of prostate cancer research, Professor Silke Gillessen shares her expertise in an exclusive interview with Oncology Frontier at the European Society for Medical Oncology (ESMO). In this enlightening discussion, Professor Gillessen delves into the innovative realm of next-generation imaging for prostate cancer. Specifically, she explores how this advanced imaging technology enhances the detection of biomarkers in advanced prostate cancer, offering promising avenues for improved diagnostics and treatment strategies
Tags:
#BiomarkerDetection#CancerResearch#ESMOInsights#MedicalOncology#NextGenerationImaging#OncologyFrontier#ProfessorSilkeGillessen#ProstateCancer
Last updated on 2024.01.13
